© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
April 15, 2022
Antimicrobial stewardship efforts, such as education for healthcare providers, significantly decreased community-acquired pneumonia antibiotic prescriptions in COVID-19 patients.
Concomitant antibiotic (CA) use for infection treatment is a major risk factor for recurrent C difficile infection. One SHEA 2022 study examined whether fidaxomicin or vancomycin would be more beneficial for CA patients.
April 14, 2022
A study presented at the SHEA 2022 conference determined how common and severe breakthrough infections were for Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccine recipients.
April 13, 2022
A survey’s results show updating programs is largely dependent on resources and dedicated personnel.
An examination of COVID-19 infections by occupation found that most cases occurred in people who worked in management and healthcare, and COVID-19 death rates were highest among building/grounds cleaning and maintenance employees.
A study found that hospital providers who prescribe unnecessarily high rates of antibiotics are likely to continue doing so over time.
April 12, 2022
A large veterans health administration study estimated antibiotic use during the last 6 months of life for patients under hospice or palliative care.
The risk of a community-acquired C difficile infection was 7-fold higher for outpatients with antibiotic exposure.
During the COVID-19 pandemic, use of community-acquired pneumonia antibiotics increased significantly, while relative utilization of carbapenems decreased.
April 17, 2021
Results from the study data reinforce the need to adhere to public health measures by people who have been vaccinated.
Oral Sabizabulin Reduces COVID-19 Deaths in High-Risk Adults
Pneumonic Plague in an Era of COVID-19
FDA: Pharmacists Can Prescribe Paxlovid to Eligible Patients
Utilizing Global Surveillance to Develop a Syphilis Vaccine